Jafron Financial Statements From 2010 to 2025
| 300529 Stock | 26.39 0.06 0.23% |
Check Jafron Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jafron Biomedical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Jafron financial statements analysis is a perfect complement when working with Jafron Biomedical Valuation or Volatility modules.
Jafron |
Jafron Biomedical Co Company Current Valuation Analysis
Jafron Biomedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Jafron Biomedical Current Valuation | 20.03 B |
Most of Jafron Biomedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jafron Biomedical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Jafron Biomedical Co has a Current Valuation of 20.03 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Jafron Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jafron Biomedical's current stock value. Our valuation model uses many indicators to compare Jafron Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jafron Biomedical competition to find correlations between indicators driving Jafron Biomedical's intrinsic value. More Info.Jafron Biomedical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Jafron Biomedical Co is roughly 2.35 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Jafron Biomedical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Jafron Biomedical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Jafron Biomedical Financial Statements
Jafron Biomedical stakeholders use historical fundamental indicators, such as Jafron Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Jafron Biomedical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Jafron Biomedical's assets and liabilities are reflected in the revenues and expenses on Jafron Biomedical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Jafron Biomedical Co. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Jafron Stock
Jafron Biomedical financial ratios help investors to determine whether Jafron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jafron with respect to the benefits of owning Jafron Biomedical security.